cropper

The Silver Surfer
Senior Citizens Surfing the Internet

  • Home
  • Categories
    • Health & Wellness
    • Money & Legal
    • Housing & Living
    • Lifestyle & Leisure
    • Technology for Seniors
    • Local Resources
May 13.2025
3 Minutes Read

Discover Easy Recipes for Feel-Good Eating That Delight Your Senses

In the Kitchen: Easy Recipes for Feel-Good Eating

Easy and Delicious Recipes for Feel-Good Eating

Cooking healthy meals shouldn’t feel like a chore, especially when you can create dishes that are both simple and bursting with flavor. Today, we’re celebrating feel-good eating with two delightful recipes that not only tantalize your taste buds but also pack a nutritional punch. Perfect for busy individuals or those just looking for a light meal, these dishes emphasize quick prep and wholesome ingredients, ensuring you spend less time in the kitchen and more time enjoying your delicious creations.

Refreshing Cranberry Chicken Salad: The Perfect Lunch

Imagine enjoying a refreshing meal that combines tender chicken, crunchy celery, and the sweetness of dried cranberries. The Cranberry Chicken Salad is ideal for a satisfying lunch or as a light dish to take on a picnic. This vibrant salad is not only easy to make but also provides ample protein and flavor, making it a fantastic choice for anyone looking to fuel their day effectively.

How to Make Your Cranberry Chicken Salad

Ingredients:
- 1 Roasted Chicken
- 1 Cup Chopped Celery
- 1 Cup Dried Cranberries
- 1 Cup Diced Red Onion (Optional)
- 1 Cup Almond Slices
- Salt & Pepper to taste

Dressing:
- ½ Cup Mayonnaise
- ½ Cup Greek Yogurt
- 1 Tablespoon of Lemon Juice

Instructions:
1. Remove the meat from the roasted chicken and chop into bite-sized pieces.
2. In a bowl, whisk together the mayonnaise, Greek yogurt, and lemon juice to create the dressing.
3. Combine the chicken, celery, cranberries, onion, and almonds in a large mixing bowl, pouring the dressing over the top.
4. Season to taste with salt and pepper, then refrigerate for at least an hour to let the flavors meld.

Indulgent yet Healthy: Cottage Cheese Edible Cookie Dough

If you’re looking for a sweet treat that won’t derail your healthy eating goals, look no further than Cottage Cheese Edible Cookie Dough. This innovative recipe reimagines the classic cookie dough, using cottage cheese as a nutritious base. Packed with protein and naturally sweet, it’s an enjoyable dessert that can be guilt-free!

Crafting Your Cookie Dough Treat

Ingredients:
- 2 Cups Cottage Cheese
- ¼ Cup Maple Syrup
- 2 Teaspoons Vanilla Extract
- ½ Cup Vanilla Protein Powder
- 1-2 Cups Almond Flour
- 1 Cup Chocolate Chips

Instructions:
1. In a mixing bowl, combine the cottage cheese, maple syrup, and vanilla extract until smooth.
2. Gradually stir in the protein powder and almond flour until you reach a dough-like consistency.
3. Fold in your chocolate chips, adjusting the sweetness or consistency with additional syrup or flour if needed.
4. Enjoy straight from the bowl or chill in the fridge for a firmer texture.

Why Healthy Cooking Matters

Eating nutritious meals can have a profound impact on quality of life, particularly as we age. Simple, wholesome recipes like these foster not only better physical health but also encourage social interaction and enjoyment during mealtimes. Sharing meals with friends or family can enhance bonds, making each cooking experience a rewarding, shared journey.

Take Your Cooking to the Next Level

Cooking for oneself or loved ones doesn’t have to be complicated. With these two feel-good recipes, you can create meals that are both satisfying and nourishing without breaking a sweat. Dive into these easy-to-follow recipes today and discover how delightful healthy eating can truly be. Enjoy the process, savor the flavors, and create lasting memories around your table!

Health & Wellness

16 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
11.19.2026

Breakthrough Insights: Diranersen Therapy Shows Benefits for Alzheimer's Patients Over Two Years

Update Understanding Tau Therapy's Promising Benefits for Alzheimer's Patients In a remarkable breakthrough for Alzheimer's research, diranersen, an investigational medication, continues to show significant benefits in slowing the decline of cognitive abilities. Recent findings from a two-year study confirm that this therapy works by targeting tau protein, a key factor in the progression of Alzheimer's disease. Presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference, Dr. Lawren VandeVrede from the University of California San Francisco highlighted that over 96 weeks, diranersen led to a meaningful recovery in cognitive functions. How Diranersen Works and Its Impact on Cognitive Decline Diranersen is an antisense oligonucleotide therapy that aims to reduce tau levels, which can collect in the brain and contribute to the disease's progression. The results showed a 1.09-point improvement in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score among participants who received a 60-mg dose twice a year. This dosage displayed the most significant results, proving invaluable since a one-point change in CDR-SB is considered clinically meaningful. A Closer Look at the Study and Its Findings The CELIA trial enrolled 416 participants with mild cognitive impairment from Alzheimer's disease and tested different doses of diranersen. Interestingly, while various dosages were evaluated, the lower 60-mg dose performed the best, leading to a 38% improvement in cognitive measures between 76 and 96 weeks. As the findings continue to evolve, researchers are optimistic about this therapy's potential to enhance cognitive function for a longer duration, which could mean new hope for patients struggling with this debilitating disease. Safety and Future Implications of Diranersen While the results are promising, it is important to consider the safety profile. During the study, adverse events were common but mostly mild, such as headaches and post-lumbar puncture syndrome. These findings continuously reassure researchers about the therapy's tolerability. Experts emphasize that diranersen's ability to lower tau without affecting amyloid protein makes it particularly exciting. This presents a potential strategy in combined therapies that target multiple aspects of Alzheimer's, aiming for a more comprehensive approach to treatment. Looking Ahead: The Future of Alzheimer's Treatments The upcoming phase III trials will be crucial in confirming the effectiveness and safety of diranersen on a larger scale. As Laura Nisenbaum, interim chief science officer of the Alzheimer's Drug Discovery Foundation, points out, understanding how tau therapy can work alongside traditional anti-amyloid treatments could be groundbreaking in the fight against Alzheimer's disease. As Alzheimer's affects millions, continued research like this offers hope and insight into managing and potentially reversing symptoms. Stay informed about these developments as they may mark a new era in Alzheimer's treatment that could benefit not just today’s patients but future generations.

11.18.2026

Why High Cardiac Troponin I Readings Alone Aren't Enough

Update Understanding Cardiac Troponins: The Basics Cardiac troponins, particularly troponin I (cTnI), are essential blood markers that help doctors understand heart health. These proteins are released when the heart is damaged, and measuring their levels can help indicate the risk of cardiovascular problems. However, recent research warns that simply looking at cTnI levels might not give the whole picture. What Are Macrotroponins and Why Do They Matter? Macrotroponins are complex molecules formed from autoantibodies attaching to troponin. They are much larger than regular troponins and can linger in the bloodstream longer, making tests show heightened cTnI levels. In simple terms, while doctors often look at high cTnI levels to assess heart health, they must also consider if these high levels are due to macrotroponins. New Findings from Norway: A Wake-Up Call In a significant study from Norway involving over 3,700 community members, researchers discovered some surprising truths. Those with high cTnI readings and no macrotroponins faced a staggering 50% chance of developing cardiovascular problems over 8.3 years. In contrast, those with high cTnI but also possessing macrotroponins had a much lower incident rate of just 6.8%. Why Misclassifying Risks Can Be Dangerous This misclassification could lead to critical oversights in patient care. High cTnI readings can indicate severe risk, but if macrotroponins are present, the actual risk may be much lower. Thus, it’s imperative for physicians to consider both cTnI levels and the presence of macrotroponins to make informed medical decisions. The Need for Enhanced Diagnostic Practices The study emphasizes that by recognizing the influence of macrotroponins, healthcare providers can improve their assessments of cardiac risk. This means creating fresh guidelines that factor in both troponin levels and macrotroponin presence could be monumental in shaping more accurate health responses. Final Thoughts: What This Means for Patients For those monitoring heart health, these insights are crucial. Patients should be aware that high cTnI does not automatically signal danger, especially if macrotroponins are present. Engaging in discussions with healthcare providers about testing methods and what results actually indicate can empower patients to better understand their cardiovascular risks.

11.17.2026

The Hidden Dangers of Agent Orange: Linking Exposure to Parkinson's Disease

Update Understanding the Link Between Agent Orange and Parkinson’s Disease Recent research has unveiled significant findings regarding the health risks faced by Vietnam-era military veterans exposed to Agent Orange, a potent herbicide used during the Vietnam War. A study of over 4 million Veterans Affairs (VA) health records has established that these veterans are at a 57% higher risk of developing Parkinson's disease and other neurodegenerative disorders. This alarming statistic indicates that veterans were not just courageous soldiers but also faced long-term health consequences from their service. What Is Agent Orange? Agent Orange was a toxic herbicide extensively utilized by the U.S. military to clear vegetation and expose enemy positions. This chemical was not just an ordinary weedkiller; it was a mixture containing 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), along with TCDD, a highly toxic dioxin. Despite the phasing out of 2,4,5-T in the 1970s, the use of 2,4-D remains prevalent today across various sectors, including agriculture and landscaping, which raises critical public health questions. Health Impacts of Agent Orange on Veterans The study led by Dr. Gregory Scott and his team highlights that veterans who handled Agent Orange directly had even higher chances—up to twice as likely—of developing Parkinson’s disease and related conditions, including REM sleep behavior disorder. This reinforces the long-held suspicions of healthcare providers and the veterans themselves regarding the link between Agent Orange exposure and neurodegenerative diseases. Broader Implications Beyond Veterans Time and again, evidence suggests that the toxic effects of Agent Orange are not limited to veterans alone. People living near agricultural areas where 2,4-D is used—like farmers and groundskeepers—face similar risks. Notably, recent studies revealed that living close to golf courses is associated with a 126% increased risk of Parkinson's disease, illustrating how widespread this issue is beyond military circles. Why Does This Matter Now? As we continue to learn about the long-term consequences of Agent Orange exposure, it becomes increasingly clear that proactive measures should be taken to prevent future exposures to harmful herbicides and pesticides. Dr. Scott emphasizes the need for immediate action to comprehend and address the health risks associated with newer herbicides before they become entrenched in our understanding, just as Agent Orange was for veterans. Conclusion: A Call for Awareness The findings of this recent study are a wake-up call for not only veterans but for communities across the U.S. As the knowledge of dangerous chemicals continues to evolve, so too must our efforts to protect public health. Advocacy for research into environmental health effects and vigilant monitoring of agricultural chemicals are imperative to safeguard both current and future generations. Understanding these risks can lead to stronger policies protecting veterans and civilians alike.

Silver Surfer Media

A division of

Electronic Commerce Engineering Corporation

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6

+19085200096

AVAILABLE FROM 9AM - 5PM

Monday ~ Friday

Green Township, New Jersey

 07860-5406

ABOUT US

The Sussex County Advisor is operated by synergetic.media a subsidiary of  Electronic Commerce Engineering Corporation, Green Township, NJ 07860-5406

© 2026 Electronic Commerce Engineering Corporation All Rights Reserved. 16 Wintermute Rd, Green Township, NJ 07860-5406 . Contact Us . Terms of Service . Privacy Policy

{"company":"Electronic Commerce Engineering Corporation","address":"16 Wintermute Rd","city":"Green Township","state":"NJ","zip":"07860-5406","email":"info@ecommerceengineering.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*